At visit one, 35 (5.6%) subjects were identified with biochemical hypogonadism. Moreover, an increase in levels of SHBG was observed with aging (Fig. 2C). Data were adjusted in theoretical models for possible confounding variables where Model 1 included age and waist-to-hip ratio (WHR) as continuous variables. Descriptive statistics were used to standardize baseline logCRP variables in all analyses. Levels of TT remained almost constant until the age of 50, after which they declined somewhat more slowly compared to the decrease in cBT (Fig. 2A and B). Mean age at the first visit was 49.2 ± 11.6 and 58.9 ± 11.8 years at the second visit (Table 1). Testosterone was set as the dependent variable (TT and calculated bioavailable testosterone (cBT)) with logCRP as the independent variable. Characteristics of the study population were assessed using descriptive statistics to calculate means and confidence intervals. Calculation of bioavailable testosterone was done using the formula according to Vermuelen et al. (18). Blood pressure was measured in the supine position after 5 min of rest at baseline and follow-up. Non-fasting blood samples were collected close to waking time (median time since awakening 3 h 38 min) to control for diurnal variation in hormone levels. Interviews were completed with 63.3% of eligible subjects, resulting in a total sample of 5504 adults (2301 men, 3203 women, 1767 Black, 1877 Hispanic, 1859 White respondents). Detailed methods have been described elsewhere.9 In brief, BACH used a multi-stage stratified random sample to recruit approximately equal numbers of subjects according to age (30–39, 40–49, 50–59, 60–79 years), gender, and race/ethnic group (African American (Black), Hispanic, and Caucasian (White)). The BACH survey is a population-based epidemiologic survey of a broad range of urologic symptoms and risk factors in a randomly selected sample. A positive trend between estradiol (total and free) and CRP levels was not statistically significant. However, CRP is known to be unspecific, and the use of other inflammatory markers such as IL-6 might provide a more precise estimate of inflammation (3, 36). In our study, questionnaires on clinical symptoms were included only at the second visit. Another limitation of the study is the possibility of evaluation of body composition with radiological techniques that could have given a more precise estimation of abdominal obesity. According to the European Urology Association guidelines on testosterone measurement, both immuno-assay and mass spectrometry, providing a reference range for normal men, would be applicable with reliable results (6). Results from the BACH study demonstrate, in a community-based sample of men, an inverse association of CRP with total and free testosterone as well as SHBG. Using data from the Boston Area Community Health (BACH) Survey, the objectives of this analysis were to investigate the association between CRP and sex hormone levels in a racially and ethnically diverse population-based sample of men. Further studies are needed to confirm the longitudinal association between CRP and androgen levels, adjusting for different confounding cytokines and underlying mechanisms to better understand the possible impact of inflammation on sexual hormonal secretion and male health. Finally, CRP was used as a marker for sub-inflammatory concentrations in this study. Other cross-sectional studies suggest that obesity largely could explain in most part the association between inflammatory markers and testosterone levels (27, 28, 29, 30, 31). There is a great number of studies investigating the association of testosterone levels with inflammatory markers, seemingly to confirm evidence of the association, remaining significant even after adjustments for obesity. In addition, recent clinical studies have suggested a bidirectional association between concentrations of cytokines stimulated by obesity and testosterone (8). Biochemical hypogonadism was defined as total testosterone levels Results from previous observational studies of the association of sex hormone levels and inflammatory markers have not been consistent. Free testosterone (FT) and estradiol (FE2) concentrations were calculated from total T (TT) or E2 and SHBG concentrations using mass action equations assuming a fixed albumin concentration.10 RIA technique has been considered a less reliable measurement method of testosterone levels compared to mass spectrometry, especially at lower levels (40). However, the use of two measurements could also strengthen the study as it would permit the investigation of these associations in a prospective design. A limitation was the change of the method used for measurements of testosterone during the study. Of the 1,559 men included in the analysis, 87 (5.6%) had missing data on one or more covariates. As results for T and SHBG were similar when conducted on the larger group of men with these measures available compared to the subgroup of men with complete data on all hormones and CRP, results are presented for the subgroup of 1,559 men. A total of 12 men with missing or extreme values for T and SHBG were excluded from the analysis. Of the 2,301 men in BACH, blood samples were obtained for 1,899 (82.5%). The objective of this analysis was to investigate the association between sex hormone levels and C-reactive protein (CRP) in a population-based sample of men. We studied the effects of normalisation of plasma testosterone levels in an open, nonrandomised study. Therefore, we were only able to observe biochemical hypogonadism in the longitudinal analyses.